These data are consistent with that of recent publications of Survivin expression in breast and gastric carcinomas, which demonstrated that lower nuclear expression of Survivin was an independent prognostic indicator of poor prognosis (Okada et al, 2001; Kennedy et al, 2003). This evidence concerns the gene BIRC5 and gastric carcinoma.